Page 16 - Ecole Polytechnique Federale de Lausanne

Oncology & Cancer

Treating tumors with engineered dendritic cells

Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way to ...

Neuroscience

Building artificial neurons with mathematics

EPFL's Blue Brain Project has found a way to use only mathematics to automatically draw neurons in 3D, meaning we are getting closer to being able to build digital twins of brains.

Oncology & Cancer

Targeting "anti-tumor" genes to provide better treatment for leukemia

Chronic lymphocytic leukemia (CLL) is one of the most common blood cancers in adults. The disease originates in B cells—the part of the immune system that produces antibodies—and then evolves slowly, typically affecting ...

Neuroscience

Brain 'noise' keeps nerve connections young

Neurons communicate through rapid electrical signals that regulate the release of neurotransmitters, the brain's chemical messengers. Once transmitted across a neuron, electrical signals cause the juncture with another neuron, ...

Neuroscience

New anti-ALS drug receives Orphan Drug designation

A new gene therapy for treating an inherited form of Amyotrophic Lateral Sclerosis has been given an Orphan Drug designation by the European Medicines Agency. The therapy is already in preclinical development at EPFL.

Neuroscience

Seeing through the eyes of a mouse by decoding its brain signals

Is it possible to fully reconstruct what someone sees based on brain signals alone? The answer is no, not yet. But EPFL researchers have made an important step in that direction by introducing a new algorithm for building ...

page 16 from 38